These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 21056072

  • 1. Elevated expression of urotensin II and its receptor in diethylnitrosamine-mediated precancerous lesions in rat liver.
    Wang H, Dong K, Xue X, Feng P, Wang X.
    Peptides; 2011 Feb; 32(2):382-7. PubMed ID: 21056072
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of urotensin II and its receptor contributes to human hepatocellular carcinoma growth via activation of the PKC, ERK1/2, and p38 MAPK signaling pathways.
    Yu XT, Wang PY, Shi ZM, Dong K, Feng P, Wang HX, Wang XJ.
    Molecules; 2014 Dec 12; 19(12):20768-79. PubMed ID: 25514221
    [Abstract] [Full Text] [Related]

  • 3. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 4. Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse.
    Wang HX, Zeng XJ, Liu Y, Wang J, Lu LQ, Hao G, Zhang LK, Tang CS.
    Regul Pept; 2009 Apr 10; 154(1-3):85-90. PubMed ID: 19323985
    [Abstract] [Full Text] [Related]

  • 5. The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues.
    Zeng ZP, Liu GQ, Li HZ, Fan XR, Liu DM, Tong AL, Zheng X, Liu C.
    Ann N Y Acad Sci; 2006 Aug 10; 1073():284-9. PubMed ID: 17102097
    [Abstract] [Full Text] [Related]

  • 6. Urotensin II is an autocrine/paracrine growth factor for aortic adventitia of rat.
    Zhang Y, Li Y, Wei R, Wang Z, Bu D, Zhao J, Pang Y, Tang C.
    Regul Pept; 2008 Nov 29; 151(1-3):88-94. PubMed ID: 18955090
    [Abstract] [Full Text] [Related]

  • 7. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
    Wang ZJ, Ding WH, Shi LB, Bu DF, Ren ZW, Tang CS.
    Zhonghua Yi Xue Za Zhi; 2006 Jan 24; 86(4):242-6. PubMed ID: 16677503
    [Abstract] [Full Text] [Related]

  • 8. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
    Hirose T, Takahashi K, Mori N, Nakayama T, Kikuya M, Ohkubo T, Kohzuki M, Totsune K, Imai Y.
    Peptides; 2009 Jun 24; 30(6):1124-9. PubMed ID: 19463745
    [Abstract] [Full Text] [Related]

  • 9. The signal transduction pathway in the proliferation of airway smooth muscle cells induced by urotensin II.
    Chen YH, Zhao MW, Yao WZ, Pang YZ, Tang CS.
    Chin Med J (Engl); 2004 Jan 24; 117(1):37-41. PubMed ID: 14733770
    [Abstract] [Full Text] [Related]

  • 10. Age-Related Reduction of Contractile Responses to Urotensin II Is Seen in Aortas from Wistar Rats but Not from Type 2 Diabetic Goto-Kakizaki Rats.
    Matsumoto T, Watanabe S, Kobayashi S, Ando M, Taguchi K, Kobayashi T.
    Rejuvenation Res; 2017 Apr 24; 20(2):134-145. PubMed ID: 27841739
    [Abstract] [Full Text] [Related]

  • 11. Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy.
    Dai HY, Guo XG, Ge ZM, Li ZH, Yu XJ, Tang MX, Zhang Y.
    J Diabetes Complications; 2008 Apr 24; 22(2):137-43. PubMed ID: 18280445
    [Abstract] [Full Text] [Related]

  • 12. Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol.
    Zhang YG, Li YG, Liu BG, Wei RH, Wang DM, Tan XR, Bu DF, Pang YZ, Tang CS.
    Acta Pharmacol Sin; 2007 Jan 24; 28(1):36-43. PubMed ID: 17184580
    [Abstract] [Full Text] [Related]

  • 13. Urotensin-II-Mediated Reactive Oxygen Species Generation via NADPH Oxidase Pathway Contributes to Hepatic Oval Cell Proliferation.
    Yu X, Wang P, Shi Z, Dong K, Feng P, Wang H, Wang X.
    PLoS One; 2015 Jan 24; 10(12):e0144433. PubMed ID: 26658815
    [Abstract] [Full Text] [Related]

  • 14. Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro.
    Spinazzi R, Albertin G, Nico B, Guidolin D, Di Liddo R, Rossi GP, Ribatti D, Nussdorfer GG.
    Int J Mol Med; 2006 Dec 24; 18(6):1107-12. PubMed ID: 17089015
    [Abstract] [Full Text] [Related]

  • 15. Enhanced renal sensitivity of the spontaneously hypertensive rat to urotensin II.
    Abdel-Razik AE, Balment RJ, Ashton N.
    Am J Physiol Renal Physiol; 2008 Oct 24; 295(4):F1239-47. PubMed ID: 18701623
    [Abstract] [Full Text] [Related]

  • 16. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
    He S, Dibas A, Yorio T, Prasanna G.
    Exp Biol Med (Maywood); 2007 Mar 24; 232(3):370-84. PubMed ID: 17327470
    [Abstract] [Full Text] [Related]

  • 17. Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure.
    Nakayama T, Hirose T, Totsune K, Mori N, Maruyama Y, Maejima T, Minagawa K, Morimoto R, Asayama K, Kikuya M, Ohkubo T, Hashimoto J, Kohzuki M, Takahashi K, Imai Y.
    Peptides; 2008 May 24; 29(5):801-8. PubMed ID: 18314225
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy.
    Langham RG, Kelly DJ, Gow RM, Zhang Y, Dowling JK, Thomson NM, Gilbert RE.
    Am J Kidney Dis; 2004 Nov 24; 44(5):826-31. PubMed ID: 15492948
    [Abstract] [Full Text] [Related]

  • 19. Effect of urotensin II on PC12 rat pheochromocytoma cells.
    Aita Y, Kasahara T, Isobe K, Kawakami Y, Takekoshi K.
    J Neuroendocrinol; 2010 Feb 24; 22(2):83-91. PubMed ID: 20025629
    [Abstract] [Full Text] [Related]

  • 20. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM.
    J Pharmacol Exp Ther; 2009 Jun 24; 329(3):1063-70. PubMed ID: 19258520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.